Stock listing

A1W50M Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: A1W50M · LS · EUR · DE

A1W50M:LS is the listing for Fate Therapeutics, Inc., a biotechnology company specializing in cellular immunotherapies for cancer and immune disorders. Based in the United States, the company is dedicated to advancing innovative therapies through extensive research and development in regenerative medicine. With a market capitalization of around €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, focusing on improving treatment options for patients. Recent news and filings reflect the company's ongoing commitment to its therapeutic advancements and market presence.

A1W50M:LSEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
A1W50M:LS
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Fate Therapeutics, Inc. A1W50M:LS stock context

A1W50M:LS is the listing for Fate Therapeutics, Inc., a biotechnology company specializing in cellular immunotherapies for cancer and immune disorders. Based in the United States, the company is dedicated to advancing innovative therapies through extensive research and development in regenerative medicine. With a market capitalization of around €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, focusing on improving treatment options for patients. Recent news and filings reflect the company's ongoing commitment to its therapeutic advancements and market presence.

Research Fate Therapeutics, Inc.

Alternate listings